Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carticel for knee cartilage defects
NCT00158613Phase 4Completed
- Sponsor
- Vericel
- Start
- Mar 2000
- Primary completion
- Nov 2005
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of autologous cultured chondrocytes in Articular cartilage defect of the knee, sponsored by Vericel. Primary endpoint: Mean change from baseline in the Knee injury and Osteoarthritis Outcome Score at 48 months. Started Mar 2000; status: completed.
02
Drugs
autologous cultured chondrocytes
03
Conditions
Articular cartilage defect of the knee
Beyond the preview
Go deeper on NCT00158613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158613.